Jaguar Health Inc expected to post a loss of $1.53 a share - Earnings Preview

Jaguar Health

11/08/2023 17:46

* Jaguar Health Inc  JAGX.OQ   JAGX.O  is expected to show a
fall
in quarterly revenue when it reports  results on August 14. 
    * The San Francisco California-based  company is expected to
report  a 21.9% decrease in revenue to $2.28 million from $2.92
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Jaguar Health Inc
is for
a loss of $1.53 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Strong Buy".​
    * Wall Street's median 12-month price target for Jaguar
Health Inc
is $6​, above​ its last closing price of $0.59. ​​​

This summary was machine generated August 11 at 16:46 GMT.  All
figures in US dollars  unless otherwise stated